| BIIB Snapshot | |
|---|---|
| Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. | |
| VALUATION DATA | |
| Market Capitalization | $29,361,467,000 | Price to Sales | 11.00 |
| Earnings per Share | $7.9800 |
| PE Ratio | 25.31 |
| PRICE DATA | |
| Most Recent Close | $208.9000 |
| 52 Week High | $2.929 |
| 52 Week Low | $1.946 |
| 50-Day Moving Average | $3.568 |
| 200-Day Moving Average | $17.22 |
| All data are from Alpha Vantage as of today. For more infomation on BIIB see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search